YTEN - メタボリックス （Yield10 Bioscience Inc.）

WOBURN, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its fourth quarter and full year 2022 financial results and provide a corporate update on Tuesday, March 14, 2023.

Yield10 Bioscience Inc (NASDAQ: YTEN ) shares are trading higher Thursday after the company signed a Memorandum of Understanding (MOU) with American Airlines Inc (NASDAQ: AAL ). What To Know: The two companies will collaborate in developing the value chain for Camelina as a low-carbon feedstock oil for sustainable aviation fuel (SAF). Camelina is an annual oilseed plant in the mustard family that is native … Full story available on Benzinga.com

WOBURN, MA / ACCESSWIRE / February 16, 2023 / Yield10 Bioscience, Inc. (NASDAQ:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, has been invited to present at the Third Annual Winter Wonderland - Best Ideas 2023 Virtual Conference, which is being held virtually on February 21 st through February 24 th , 2023. Yield10 CEO Oliver Peoples, Ph.D. is scheduled to present on Tuesday, February 21, 2023 at 1:30 pm ET in a fireside chat panel that will be hosted by Ben Klieve, CFA, Senior Research Analyst of Lake Street Capital Markets. Management will be available for one-on-one meetings with investors who are registered for the conference. The presentation will be webcast live and available for replay here . To receive additional information, request an invitation or to schedule a one-on-one meeting, please email angie.wright@issuerdirect.com . Investors can register here. About Yield10 Bioscience Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the "Trait Factory", to develop improved Camelina varieties to produce proprietary seed products, and to discover high value genetic traits for the agriculture and food industries.

Gainers: Yield10 Bioscience (YTEN) +12%. CN Energy (CNEY) +11%

Gainers: American Lithium (AMLI) +13%. Yield10 Bioscience (YTEN) +10%

Gainers Prometheus Biosciences, Inc. (NASDAQ: RXDX ) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-UC met the primary endpoint. TransCode Therapeutics, Inc. (NASDAQ: RNAZ ) shares climbed 59.1% to $0.6679 after the company reported withdrawal of registration statement. BioVie Inc. (NASDAQ: BIVI ) gained 26.2% to $5.87. BioVie recently announced results from two Phase 2 trials assessing NE3107''s potential in Parkinson''s Disease (PD) and Alzheimer''s Disease (AD). Bit Brother Limited (NASDAQ: BTB ) climbed 23.1% to $0.4680. Vor Biopharma Inc. (NASDAQ: VOR ) climbed 21.4% to $5.22 after the company disclosed initial clinical data from VBP101, its Phase 1/2a multicenter, open-label, first-in-human study of tremtelectogene empogeditemcel or “trem-cel” (formerly VOR33) in patients with acute myeloid leukemia. Vor Bio also priced underwritten offering of 15.3 million shares of common stock at $4.30 per share.

Yield10 Bioscience, Inc. (NASDAQ:NASDAQ:YTEN) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Lynne Brum – Vice President of Planning and Corporate…

The following slide deck was published by Yield10 Bioscience, Inc.

-Grower contracts in place for winter 2022/2023 -Development of herbicide tolerance traits in Camelina on track -Collaboration with Rothamsted Research for omega-3 technology extended through 2023

Yield10 Bioscience (YTEN) is scheduled to announce Q3 earnings results on Monday, November 14th, after market close.The consensus EPS Estimate is -$0.66 and the consensus Revenue…

Yield10 Bioscience, Inc. (NASDAQ:NASDAQ:YTEN) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Lynne Brum – Vice President of Planning and Corporate…

The following slide deck was published by Yield10 Bioscience, Inc.

-Grower contracts in place for winter 2022/2023 -Development of herbicide tolerance traits in Camelina on track -Collaboration with Rothamsted Research for omega-3 technology extended through 2023

Yield10 Bioscience (YTEN) is scheduled to announce Q3 earnings results on Monday, November 14th, after market close.The consensus EPS Estimate is -$0.66 and the consensus Revenue…

WOBURN, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its third quarter 2022 financial results and provide a corporate update on Monday, November 14, 2022.